These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7029950)

  • 1. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
    Tsega E
    Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delagil treatment of urocoproporphyria].
    Idel'son LI
    Klin Med (Mosk); 1980 May; 58(5):61-3. PubMed ID: 6770170
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged low-dose chloroquin therapy of porphyria cutanea tarda].
    Holvay E
    Orv Hetil; 1981 Jul; 122(30):1839-42. PubMed ID: 7301351
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
    Holvay E
    Ther Hung; 1981; 29(1):42-6. PubMed ID: 7188240
    [No Abstract]   [Full Text] [Related]  

  • 9. [Porphyria cutanea tarda and lupus erythematosus].
    Köstler E; Heinicke HJ; Schneider F; Riedel H; Hensel J
    Z Gesamte Inn Med; 1989 Sep; 44(17):527-9. PubMed ID: 2588723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
    Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
    Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
    [No Abstract]   [Full Text] [Related]  

  • 11. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyria cutanea tarda simulating scleroderma.
    Goh CL
    Singapore Med J; 1987 Feb; 28(1):83-8. PubMed ID: 3603082
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda.
    Ashton RE; Hawk JL; Magnus IA
    Br J Dermatol; 1984 Nov; 111(5):609-13. PubMed ID: 6498093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Major hypertrichosis in an adult female secondary to porphyria cutanea tarda. Its evolution with chloroquine].
    Michel B; Guillot B; Guilhou JJ; Meynadier J
    Ann Dermatol Venereol; 1983; 110(4):361-3. PubMed ID: 6625460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current therapeutic methods in porphyria cutanea tarda].
    Giannotti B
    G Ital Dermatol Venereol; 1984; 119(3):167-9. PubMed ID: 6746011
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of patients with porphyria cutanea tarda with antimalarials].
    Kordac V; Semrádová M
    Cas Lek Cesk; 1973; 112(24):762-5. PubMed ID: 4714507
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antimalarials in the treatment of porphyria cutanea tarda].
    Malina L; Chlumský J
    Cesk Dermatol; 1973 Dec; 48(6):381-6. PubMed ID: 4203841
    [No Abstract]   [Full Text] [Related]  

  • 18. Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy.
    Wennersten G; Ros AM
    Acta Derm Venereol Suppl (Stockh); 1982; 100():119-23. PubMed ID: 6962628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Riedel H; Kemmer C
    Hautarzt; 1986 Apr; 37(4):210-6. PubMed ID: 3009356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)].
    Chlumský J; Dobiás J; Chlumská A; Malina L
    Cas Lek Cesk; 1977 Nov; 116(45):1404-6. PubMed ID: 603887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.